Jan 20 2010
Neomend,
Inc., an innovator in sealant and adhesion-prevention products for the
surgical marketplace, announced it has received premarket approval from
the U.S. Food and Drug Administration (FDA) for the company’s ProGEL™
Pleural Air Leak Sealant.
“We are very excited to receive this approval and be in a position to
provide this unique technology to the surgeons and patients who greatly
need it”
ProGEL is a hydrogel polymer sealant consisting of two components: human
serum albumin and a cross-linking component of polyethylene glycol. When
they are mixed together, a rapid reaction occurs that creates a hydrogel
matrix which results in the formation of a strong, adherent and flexible
seal.
ProGEL is intended for application to visceral pleura during an open
thoracotomy after standard visceral pleural closure with, for example,
sutures or staples, of visible air leaks (≥2 mm) incurred during open
resection of lung parenchyma. ProGELTM Pleural Air Leak
Sealant is the only such product with this specific approved indication
in the United States.
“We are very excited to receive this approval and be in a position to
provide this unique technology to the surgeons and patients who greatly
need it,” said David Renzi, the company’s President and CEO. “This
technology has also been shown to reduce hospital stay days, a benefit
that can significantly reduce the total cost of these procedures to the
hospital. Neomend will move quickly to bring this important product to
market.”
FDA approval came following a multi-center clinical study on the device
that encompassed 161 patients in five institutions: Mayo Clinic,
Cedars-Sinai Medical Center, Duke University, MD Anderson Cancer Center,
and the University of Washington.
ProGEL was shown to be 77% effective in sealing air leaks
intra-operatively, compared to 16% for the control group. The device led
to a statistically significant reduction in both intraoperative air
leaks and hospital stay of nearly two days.
The newly available device addresses a current, unmet surgical need to
seal pleural air leaks incurred during lung surgery. The company
estimates approximately 150,000 lung resections are performed in the
United States every year. Intraoperative air leaks are a primary
complication of lung surgery and can lead to other complications such as
infections, pneumonia and extended hospitalization.
Source: Neomend,
Inc.